Technical Analysis for ORPH - Open Orphan Plc

Grade Last Price % Change Price Change
grade B 13.0 -1.89% -0.25
ORPH closed down 1.89 percent on Wednesday, July 29, 2020, on 40 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ORPH trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Shooting Star Candlestick Bearish -1.89%
Pocket Pivot Bullish Swing Setup -1.89%
Doji - Bearish? Reversal -1.89%
Wide Bands Range Expansion 1.17%
Narrow Range Bar Range Contraction -0.38%
Wide Bands Range Expansion -0.38%
Up 3 Days in a Row Strength -0.38%
180 Bullish Setup Bullish Swing Setup 4.00%
Pocket Pivot Bullish Swing Setup 4.00%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Venn Life Sciences Holdings plc is a clinical research organization (CRO), which is engaged in providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology and medical device organizations. The Company has the innovation segment, which is focused on developing and commercializing skin technologies. It provides drug development services through its subsidiary, Kinesis Pharma B.V. The Company's drug development services include clinical development, pharmaceutical development, non-clinical/pre-clinical development, drug candidate selection and drug development project management. The Company offers international clinical research services, including protocol development; feasibility and site selection; investigator and site selection; project management; site management and monitoring; vendor management, and quality assurance. The Company has its presence in the United Kingdom, Ireland, France, Netherlands, Germany and Singapore.
Articles Biotechnology Health Project Management Pharmaceutical Industry Drug Discovery Drug Development Clinical Trial Parexel Clinical Research Contract Research Organizations Clinical Research Services Drug Development Services Pharmaceutical Development Site Management

Is ORPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.0
52 Week Low 4.5
Average Volume 7,152,759
200-Day Moving Average 6.63
50-Day Moving Average 7.88
20-Day Moving Average 10.71
10-Day Moving Average 12.75
Average True Range 1.28
ADX 42.56
+DI 45.04
-DI 16.95
Chandelier Exit (Long, 3 ATRs ) 12.15
Chandelier Exit (Short, 3 ATRs ) 9.67
Upper Bollinger Band 15.66
Lower Bollinger Band 5.76
Percent B (%b) 0.73
BandWidth 92.52
MACD Line 1.63
MACD Signal Line 1.52
MACD Histogram 0.105
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.05
Resistance 3 (R3) 14.10 13.80 13.88
Resistance 2 (R2) 13.80 13.53 13.78 13.82
Resistance 1 (R1) 13.40 13.37 13.25 13.35 13.76
Pivot Point 13.10 13.10 13.03 13.08 13.10
Support 1 (S1) 12.70 12.83 12.55 12.65 12.24
Support 2 (S2) 12.40 12.67 12.38 12.18
Support 3 (S3) 12.00 12.40 12.13
Support 4 (S4) 11.95